This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Thomas Emrich: Innovator in Antibody Selection Methods
Introduction
Thomas Emrich is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of antibody selection methods. His innovative work has led to advancements that are crucial for various applications in medicine and research.
Latest Patents
Thomas Emrich holds a patent for an antibody selection method. This patent represents a key development in the efficient identification and selection of antibodies, which are essential tools in therapeutic and diagnostic applications. He has 1 patent to his name, showcasing his expertise and commitment to innovation.
Career Highlights
Emrich is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company allows him to work on cutting-edge projects that aim to improve health outcomes through innovative solutions. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Thomas has collaborated with esteemed colleagues such as Wolfgang Richter and Hubert Kettenberger. These partnerships have fostered a collaborative environment that enhances the development of new technologies and methodologies in the field.
Conclusion
In summary, Thomas Emrich is a distinguished inventor whose work in antibody selection methods has made a significant impact in biotechnology. His contributions at Hoffmann-La Roche Inc. and collaborations with other experts highlight his dedication to advancing medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
